PEPTONIC medical AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was SEK 9.92 million compared to SEK 12.37 million a year ago. Net loss was SEK 7.49 million compared to SEK 8.52 million a year ago. Basic loss per share from continuing operations was SEK 0.01 compared to SEK 0.04 a year ago.
For the nine months, revenue was SEK 31.2 million compared to SEK 34.48 million a year ago. Net loss was SEK 22.97 million compared to SEK 28.83 million a year ago. Basic loss per share from continuing operations was SEK 0.02 compared to SEK 0.12 a year ago.